Oranee Daniels M.D.

Oranee Daniels MD is an accomplished clinical development consultant and medical officer with extensive experience in the pharmaceutical and biotech industries. Currently serving as Chief Medical Officer and Clinical Development Consultant at Pharma/Biotech Consulting since June 2014, Oranee provides independent advice on drug development to biotech companies and non-profit organizations. Additionally, Oranee holds the position of Director of the Board at Lotus Pharmaceutical Co., Ltd, Taiwan's largest pharmaceutical company, and previously served as Chief Medical Officer at Antiva Biosciences, Inc. With a robust background in clinical pharmacology and research, Oranee has held leadership roles at major companies including Theravance, Amgen Inc, and Eli Lilly, and has contributed to the academic field as an Assistant Professor at Chulalongkorn University. Oranee completed an MD in Clinical Pharmacology from Stanford University School of Medicine and an MSc in Cardiovascular Pharmacology from McMaster University.